Randomized Trials of Renal Denervation for Uncontrolled Hypertension: An Updated Meta-Analysis.

Syed Hamza Mufarrih Nada Qaisar Qureshi Mohammed Saud Khan Mohammed Kazimuddin Eric A Secemsky Michael J Bloch Jay S Giri Debbie L Cohen Rajesh V SwaminathanDmitriy N FeldmanKhaldoon Alaswad Ajay J Kirtane David E Kandzari Herbert D Aronow

Published in: Journal of the American Heart Association (2024)

RDN significantly lowers blood pressure in patients with uncontrolled hypertension, in patients off and on antihypertensive medications, with a favorable safety profile. The efficacy of RDN was consistent in sham-controlled trials and contemporary trials using US Food and Drug Administration-approved devices.

Keyphrases

case control
blood pressure
drug administration
hypertensive patients
end stage renal disease
heart rate
ejection fraction
newly diagnosed
systematic review
chronic kidney disease
prognostic factors
randomized controlled trial
risk assessment
patient reported outcomes
human health
weight loss